January 8, 2026
Design and Engineering of Recombinant Oncolytic Adenoviruses Expressing an Anti-EpCAM/Anti-CD3 BiTE for Targeted Immunotherapy of A549 Lung Cancer Cells
Neutral
Dove Medical Press
Owner:
Informa PLC